• patients
  • Prospective randomized Norwegian multicenter clinical trial (11 hospitals) comparing tobramycin given once a day (new regimen) vs. three times a day (current regimen), with penicillin G, to cancer patients with febrile neutropenia. (clinicaltrials.gov)
  • It has been questioned if tobramycin once a day is safe in patients with low levels of granulocytes when it is given with a drug like penicillin G which is not covering Gram-negative rods. (clinicaltrials.gov)
  • Patients were randomized to either tobramycin once or three times a day. (clinicaltrials.gov)
  • This case can indicate the possible existence of increased vulnerability to Tobramycin treatment in male patients, resulting in Renal Failure Acute side effect. (patientsville.com)
  • Approximately 85 percent of patients in the study had received at least three courses of inhaled tobramycin in the 12 months prior to randomization. (prnewswire.com)
  • Drugs
  • When using Tobramycin , the patient experienced the following unwanted symptoms/side effects:Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. (patientsville.com)
  • given
  • Like all aminoglycosides, tobramycin does not pass the gastro-intestinal tract, so for systemic use it can only be given intravenously or intramuscularly. (wikipedia.org)
  • development
  • The Tobramycin market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. (prsync.com)
  • The Tobramycin industry development trends and marketing channels are analyzed. (prsync.com)